Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,690,450
  • Shares Outstanding, K 61,226
  • Annual Sales, $ 198,320 K
  • Annual Income, $ -169,430 K
  • 60-Month Beta 0.73
  • Price/Sales 8.67
  • Price/Cash Flow N/A
  • Price/Book 5.59
Trade TVTX with:

Options Overview Details

View History
  • Implied Volatility 76.52%
  • Historical Volatility 23.82%
  • IV Percentile 31%
  • IV Rank 13.84%
  • IV High 271.19% on 01/29/21
  • IV Low 45.25% on 04/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1
  • Open Int (30-Day) 599

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.72
  • Number of Estimates 4
  • High Estimate -0.56
  • Low Estimate -0.88
  • Prior Year -2.37
  • Growth Rate Est. (year over year) +69.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.03 +2.15%
on 12/03/21
31.35 -11.93%
on 11/04/21
-3.14 (-10.21%)
since 11/03/21
3-Month
21.66 +27.47%
on 09/20/21
31.35 -11.93%
on 11/04/21
+6.48 (+30.67%)
since 09/03/21
52-Week
12.75 +116.55%
on 07/23/21
33.09 -16.56%
on 02/02/21
+2.84 (+11.47%)
since 12/03/20

Most Recent Stories

More News
Travere Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that management will present a Company overview at...

TVTX : 27.61 (-1.67%)
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will...

TVTX : 27.61 (-1.67%)
Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of 18.06% and 32.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

TVTX : 27.61 (-1.67%)
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress

Recently reported positive topline interim results from the ongoing pivotal Phase 3 PROTECT Study of sparsentan in IgA nephropathy Following pre-NDA...

TVTX : 27.61 (-1.67%)
Travere Therapeutics to Report Third Quarter 2021 Financial Results

SAN DIEGO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2021 financial...

TVTX : 27.61 (-1.67%)
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on October 10, 2021, the Compensation...

TVTX : 27.61 (-1.67%)
Travere Therapeutics Announces Transition of Chief Medical Officer

SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that its chief medical officer, Noah Rosenberg,...

TVTX : 27.61 (-1.67%)
Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Regulatory News:

TVTX : 27.61 (-1.67%)
Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand

Vifor Pharma obtains exclusive commercialization rights for sparsentan in Europe, Australia and New Zealand

TVTX : 27.61 (-1.67%)
Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors

Ms. Williams-Brinkley brings more than 35 years of executive leadership experience in healthcare to the Travere Board

TVTX : 27.61 (-1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 29.43
2nd Resistance Point 28.84
1st Resistance Point 28.22
Last Price 27.61
1st Support Level 27.01
2nd Support Level 26.42
3rd Support Level 25.80

See More

52-Week High 33.09
Last Price 27.61
Fibonacci 61.8% 25.32
Fibonacci 50% 22.92
Fibonacci 38.2% 20.52
52-Week Low 12.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar